Rinda Sama - Axonics Modulation Chief Officer
| AXNXDelisted Stock | USD 70.98 0.48 0.68% |
Executive
Mr. Rinda Sama is the Chief Operating Officer of the company. From May 2014 to August 2018, Mr. Sama served as our Vice President, Operations and Quality. From June 2011 to May 2014, Mr. Sama served as Director, Operations and Quality of Vessix Vascular, Inc since 2017.
| Age | 45 |
| Tenure | 7 years |
| Professional Marks | MBA |
| Phone | 949 396 6322 |
| Web | https://www.axonics.com |
Rinda Sama Latest Insider Activity
Tracking and analyzing the buying and selling activities of Rinda Sama against Axonics Modulation stock is an integral part of due diligence when investing in Axonics Modulation. Rinda Sama insider activity provides valuable insight into whether Axonics Modulation is net buyers or sellers over its current business cycle. Note, Axonics Modulation insiders must abide by specific rules, including filing SEC forms every time they buy or sell Axonics Modulation'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Rinda Sama over three months ago Disposition of 3392 shares by Rinda Sama of Axonics Modulation at 56.53 subject to Rule 16b-3 |
Axonics Modulation Management Efficiency
Axonics Modulation's management efficiency ratios could be used to measure how well Axonics Modulation manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Douglas Devine | iRhythm Technologies | 54 | |
| Aimee Einstein | Si Bone | N/A | |
| Marcee Maroney | Pulmonx Corp | 54 | |
| Julie Andrews | Orthofix Medical | 53 | |
| Stephanie Walsh | Orthofix Medical | N/A | |
| Scott Cundy | Medtronic PLC | N/A | |
| Michael Pisetsky | Si Bone | 46 | |
| Chantal VeillonBerteloot | Integra LifeSciences Holdings | 54 | |
| Mark Ploof | Medtronic PLC | N/A | |
| Robert Hopkins | Medtronic PLC | N/A | |
| MPH MD | Medtronic PLC | N/A | |
| Lucas Vitale | Orthofix Medical | 47 | |
| Mei Jiang | Medtronic PLC | N/A | |
| Stephen Leonard | Integra LifeSciences Holdings | 62 | |
| Gali Attias | Nano X Imaging | 45 | |
| Richard Glaze | CONMED | 58 | |
| Noga Shabshin | Nano X Imaging | N/A | |
| Orit Wimpfheimer | Nano X Imaging | 53 | |
| Gregory Smith | Medtronic PLC | 60 | |
| Ruth Fleming | Integra LifeSciences Holdings | N/A | |
| Kenneth Washington | Medtronic PLC | 64 | |
Management Performance
| Return On Equity | -0.0089 | ||||
| Return On Asset | -0.0063 |
Axonics Modulation Leadership Team
Elected by the shareholders, the Axonics Modulation's board of directors comprises two types of representatives: Axonics Modulation inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Axonics. The board's role is to monitor Axonics Modulation's management team and ensure that shareholders' interests are well served. Axonics Modulation's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Axonics Modulation's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Alfred Ford, Chief Commercial Officer | ||
| Danny Dearen, Chief Operating and Financial Officer | ||
| MD MAS, Chief Officer | ||
| Raymond Cohen, CEO, Director | ||
| Rinda Sama, Chief Officer | ||
| JD Esq, General VP | ||
| Aaron Pettit, General Officer | ||
| Kari Keese, Chief Officer | ||
| John Woock, Chief Marketing Officer | ||
| Neil Bhalodkar, Vice Relations | ||
| Guangqiang Jiang, Chief Officer |
Axonics Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Axonics Modulation a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0089 | ||||
| Return On Asset | -0.0063 | ||||
| Profit Margin | (0.01) % | ||||
| Operating Margin | (0.02) % | ||||
| Current Valuation | 3.32 B | ||||
| Shares Outstanding | 51.11 M | ||||
| Shares Owned By Insiders | 1.26 % | ||||
| Shares Owned By Institutions | 87.22 % | ||||
| Number Of Shares Shorted | 3.31 M | ||||
| Price To Earning | (10.68) X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Axonics Modulation Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Consideration for investing in Axonics Stock
If you are still planning to invest in Axonics Modulation check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Axonics Modulation's history and understand the potential risks before investing.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Stocks Directory Find actively traded stocks across global markets | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |